// November 11, 2022
Latest nitrosamines recall spotlighting need to control pharmaceutical impurities ...
Revised on: January 17, 2023
Medicines
// February 22, 2023
Innovative Matrix Framework Assesses Risk for Substandard Antibiotics...
Substandard medicines are a huge public health threat. Proactively evaluating drug products using a relative risk assessment is important to reduce the prevalence of substandard antibiotics.
// December 05, 2022
How to Help Avoid Tragedies Linked to Contaminated Cough Syrup...
The World Health Organization (WHO) recently issued a Medical Product Alert after four substandard products were identified in The Gambia, which may be linked to t
// September 23, 2022
4 Drivers of Childhood Cancer Treatment Supply Chain Vulnerability ...
Persistent and long-lasting shortages of childhood cancer treatments undermine the advancements in science that have helped to increase childhood cancer survival rates to 85 percent.
// June 23, 2022
How medicine quality affects antimicrobial resistance and the medicines supply chain ...
Learn how medicine quality affects antimicrobial resistance and the medicines supply chain
// September 09, 2021
Best Practices in State-Level Procurement in India During the COVID-19 Pandemic: Adap...
In the global race to procure vaccines, India—the world’s leading supplier of generic medicines—faces an acute shortage of COVID-19 vaccines. Often dubbed the world’s pharmacy, India must now obtain enough vaccines for its own people. The federal government is in charge of procuring COVID-19 vaccines. However, significant challenges in quality assurance—including storage, distribution, and getting shots into arms at the last mile—remain at the state level.
// August 18, 2021
USP Expands Global COVID-19 Response to Tackle Substandard & Falsified Vaccines...
The challenges posed by COVID-19 transcend international borders and require global solutions. This includes addressing the potential for substandard and falsified (SSF) COVID-19 vaccines, particularly in low- and middle-income countries. At the U.S.
// May 17, 2021
Fostering Broader Access to Quality-assured COVID-19 Vaccines from Development to Dis...
Those stakeholders involved in the development and distribution of vaccines – including developers, manufacturers, distributors, and healthcare practitioners – must all work together to maintain the quality of authorized and approved COVID-19 vaccines.
// May 05, 2021
Manufacturing COVID-19 vaccines in Africa
While the global vaccination effort to curb the spread of COVID-19 continues to ramp up worldwide, access to COVID-19 vaccines, particularly in low- and middle-income countries, remains staggeringly low. In fact, low- and middle-income countries received less than one percent of available doses.
Show 11 More